The foundation provided support to create a new working capital facility managed by UNICEF to help fund manufacturers to ramp up the production of life-saving Ready-To-Use Therapeutic Food (RUTF). This will enable suppliers to buy raw ingredients, increase staffing, and pay increased freight costs and other recurring costs on an accelerated timeline.
Investment Date: November 2022
The foundation provided support to Dr. Reddy’s Laboratories, a multinational pharmaceutical company, to expand access to generic molnupiravir in low- and middle-income countries.
Investment Date: March 2022
SwipeRx, formerly mClinica, is the is the largest network of pharmacies in southeast Asia connecting over 235,000 pharmacy professionals from 45,000 pharmacies. SwipeRx pioneered the community-driven commerce model that unites the fragmented pharmacy channel on a single platform enabling them to access all the information, education and medicines they need. From online education, to centralised purchasing and logistics, to financing, SwipeRx caters to the unique and pressing needs of pharmacies, a critical public health channel.
Investment Date: March 2022
BioFarma received support from the foundation to expand access to its novel oral poliovirus vaccine type 2 (nOPV2) for the Global Polio Eradication Initiative.
Investment Date: April 2022
The foundation provided support to UNICEF to create a pool of flexible financing to improve access to generic novel COVID-19 oral antivirals in low and middle-income countries.
Investment Date: March 2022
OneLoad facilitates financial services for small merchants in Pakistan through its micro-retailer digitisation and payment platform. The foundation invested in OneLoad to scale its interoperable airtime and cash-in, cash-out services among low-income retailers and consumers.
The foundation provided support to expand UNICEF’s Vaccine Independence Initiative. This program allows countries to bridge-finance the procurement of vaccines and other health commodities and UNICEF to procure COVID commodities in advance of country demand materialization and procurement. The financing helps countries avoid critical stock-outs of important health commodities.
Investment Date: November 2021
Inventprise is an innovative vaccine development company based out of Redmond, Washington that is focused on developing efficacious, affordable vaccines for global populations most in need. The foundation invested in the Company to advance its novel pneumococcal conjugate vaccine (“IVT-25”). As part of its investment agreement with the foundation, Inventprise has committed to make IVT-25 available and accessible at an affordable price to low- and middle-income countries. In addition, the company has agreed to make its platform available for the development of future vaccines for global health.
Investment Date: November 2021
Exscientia plc is an artificial intelligence-driven pharmaceutical company focused on discovering, designing, and developing drugs in a fast, efficient manner, with three AI-designed drugs that are in Phase 1 human clinical trials. The foundation invested in the Company to develop five phase 1-ready small molecule therapeutics to help prepare for future pandemics. The collaboration will focus on developing broad-spectrum antivirals for coronaviruses, influenza, and paramyxoviruses.
Investment Date: October 2021
Avanti Finance Private Limited is a Non-Banking Financial Company and financial technology platform in India focused on enabling financial inclusion and sustainable livelihoods through improved access to affordable, livelihoods-purpose credit for unbanked and low-income populations across the country. The foundation invested in the Company to accelerate livelihoods-purpose digital credit products delivered through responsible servicing standards and to further develop an equitable marketplace platform to reach low-income populations, especially women, in India.
Investment Date: April 2021
1mg Technologies Private Limited is a digital consumer healthcare platform in India that provides online-to-offline services to help customers access medicines, diagnostics, and tele-consultations. The foundation invested in the Company to accelerate low-cost delivery of high-quality essential medicines and other Read More
Abbott Laboratories received support from the foundation to make its Panbio COVID-19 Ag Rapid Test available to low- and middle-income countries. Making high-quality, affordable rapid diagnostic tests with results available in 15-20 minutes is critical in the fight to control Read More
Achaogen is focused on R&D and commercialization of antibacterials to combat multi-drug resistant, Gram-negative infections. The foundation’s investment is supporting the development of Achaogen’s monoclonal antibody (“mAb”) discovery platform.
Press Release
The foundation invested in Acrobatiq, a leader in adaptive learning solutions, to support the growth of a next-generation adaptive learning, courseware, and analytics program.
Press Release
The foundation has committed to further support the Global Health Investment Fund model by investing as an anchor LP in Adjuvant. Adjuvant is a private investment fund focused on late-stage life sciences investments to address global health challenges. The Fund invests Read More
Affinivax achieves unprecedented levels of immune response and disease protection by streamlining the process of vaccine design and allowing for multiple antigens to be effectively incorporated in a single vaccine.
News StoryThe foundation invested in the Africa Health Fund to provide capital to support new approaches to improving the quality and accessibility of private healthcare across the continent.
The African Agricultural Capital Fund provides growth capital to companies that boost the productivity and profitability of smallholder farmers in East Africa.
Press Release
The African Leadership Foundation is a U.S. 501(c)(3) organization with a mission to educate Africa’s next generation of young leaders. The foundation provided a loan to support the organization’s 2020-2021 school year objectives. Investment Date: May 2020
AgBiome is focused on discovery and development of biological and transgenic products for crop protection. AgBiome identifies microbes from a wide variety of sources to harness their natural abilities to help crops resist pests and stresses.
Press Release